Tumor angiogenesis at baseline identified by (18)F-Alfatide II PET/CT may predict survival among patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

BACKGROUND: The study investigated the predictive value of tumor angiogenesis observed by (18)F-ALF-NOTA-PRGD2 II (denoted as (18)F-Alfatide II) positron emission tomography (PET)/computed tomography (CT) before concurrent chemoradiotherapy (CCRT) for treatment response and survival among patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Yuchun, Qin, Xueting, Liu, Xiaoli, Zheng, Jinsong, Luan, Xiaohui, Zhou, Yue, Yu, Jinming, Yuan, Shuanghu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811991/
https://www.ncbi.nlm.nih.gov/pubmed/35109866
http://dx.doi.org/10.1186/s12967-022-03256-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811991/
https://www.ncbi.nlm.nih.gov/pubmed/35109866
http://dx.doi.org/10.1186/s12967-022-03256-3

Ejemplares similares